way 100135 has been researched along with sch 23390 in 3 studies
| Studies (way 100135) | Trials (way 100135) | Recent Studies (post-2010) (way 100135) | Studies (sch 23390) | Trials (sch 23390) | Recent Studies (post-2010) (sch 23390) |
|---|---|---|---|---|---|
| 143 | 0 | 34 | 803 | 0 | 585 |
| Protein | Taxonomy | way 100135 (IC50) | sch 23390 (IC50) |
|---|---|---|---|
| D(2) dopamine receptor | Homo sapiens (human) | 1.0405 | |
| D | Rattus norvegicus (Norway rat) | 0.001 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 0.0461 | |
| D(1B) dopamine receptor | Homo sapiens (human) | 0.0011 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0006 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.3891 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furuyashiki, T; Miyamoto, C; Narumiya, S; Ohinata, K; Suzuki, C | 1 |
| Kanamoto, R; Mizushige, T; Ohinata, K; Sawashi, Y; Yamada, A | 1 |
| Abbasi-Maleki, S; Mesbahzadeh, B; Moradi-Kor, N | 1 |
3 other study(ies) available for way 100135 and sch 23390
| Article | Year |
|---|---|
Central PGE2 exhibits anxiolytic-like activity via EP1 and EP4 receptors in a manner dependent on serotonin 5-HT1A, dopamine D1 and GABAA receptors.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Benzazepines; Bicuculline; Brain; Dinoprostone; Flumazenil; GABA Modulators; GABA-A Receptor Antagonists; Male; Mice; Mice, Knockout; Neuropsychological Tests; Piperazines; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D1; Receptors, GABA-A; Receptors, Prostaglandin E, EP1 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Serotonin Antagonists | 2011 |
Characterization of Tyr-Leu-Gly, a novel anxiolytic-like peptide released from bovine αS-casein.
Topics: Amino Acid Sequence; Animals; Anti-Anxiety Agents; Benzazepines; Bicuculline; Carboxypeptidases; Caseins; Cattle; Dose-Response Relationship, Drug; Gastrointestinal Tract; Male; Maze Learning; Mice; Molecular Sequence Data; Motor Activity; Oligopeptides; Pancreatic Elastase; Pancreatin; Pepsin A; Peptide Hydrolases; Piperazines; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D1; Receptors, GABA-A; Trypsin | 2013 |
Zinc enhances the expression of morphine-induced conditioned place preference through dopaminergic and serotonergic systems.
Topics: Animals; Benzazepines; Conditioning, Psychological; Dopamine Antagonists; Haloperidol; Ketanserin; Male; Morphine; Ondansetron; Piperazines; Rats; Rats, Wistar; Reward; Serotonin Antagonists; Sulpiride; Zinc | 2019 |